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Aim: The accuracy of treatment planning systems is of vital importance in treatment out-
comes in brachytherapy. In the current study the accuracy of dose calculations of a high
dose rate (HDR) brachytherapy treatment planning system (TPS) was validated using the
Monte Carlo method.
Materials and methods: Three 60Co sources of the GZP6 afterloading brachytherapy system
were modelled using MCNP4C Monte Carlo (MC) code. The dose distribution around all the
sources was calculated by MC and a dedicated treatment planning system. The results of
both methods were compared.Results: There was good agreement (<2%) between TPS andMC calculated dose distributions
except at a point near the sources (<1 cm) and beyond the tip of the sources.
Conclusions: Our study conﬁrmed the accuracy of TPS calculated dose distributions for clin-
ical use in HDR brachytherapy.
© 2009 Wielkopolskie Centrum Onkologii. Published by Elsevier Urban & Partner Sp. z.o.o.1. Background
Calculation of absorbed dose distribution in a patient before
treatment is one of the main steps in radiation therapy treat-
ment planning. In high dose rate (HDR) brachytherapy, the
accuracy of calculation becomes a stringent issue because of
the higher dose rate and prescribed dose per session.1–3 Thus,
inaccuracies in dose distributions may lead to a higher dose
to limiting normal tissue or lower target dose. The algorithms
implemented in conventional treatment planning systems are
based on analytical methods such as Sievert integration or
newly developed methods such as convolution and Monte
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Carlo (MC) methods.4–6 Experimental methods including ﬁlm
and thermoluminescence dosimetry in solid phantoms have
been traditionally used to validate the accuracy of TPS before
clinical use of a TPS in brachytherapy.7–9 In the last decade,
the MC method has been widely used in different brachyther-
apy techniques as a tool for validation of dose calculations
in patient anatomy and phantoms.9–14 In a recent study on
the application of MC code for brachytherapy calculations, the
Brachydose MC code was assessed and its calculated dosime-
try parameterswere comparedwith values calculated by other
authors using PTRAN code and to measured values. Overall,l, Attar Street, Tabriz, Iran. Tel.: +98 411 3364660;
calculations made with Brachydose showed good agreement
with PTRAN results.15 The study of Poon et al. on the dosi-
metric properties of a novel intracavitary mould applicator
for 192Ir high dose rate (HDR) using the MC and experimental
Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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ethod showed a good agreement between the experimen-
al and the GEANT4 calculations.12 In previous studies, in-air
ose rate measurements and calculation of radial dose func-
ion of sources were carried out as part of acceptance testing
f a new brachytherapy unit.10,16
. Aim
n an MC study, we modelled three sources of a new HDR 60Co
rachytherapy unit and compared the radial dose functions of
C calculations with a dedicated TPS.10 The results exhibited
good agreement between MC and TPS calculated radial dose
unctions. In the current study, to have more information on
he accuracy of TPS isodose calculations, the isodoses of three
ources were calculated by MCNP4C MC code and compared
ith TPS calculations.
. Materials and methods
.1. HDR 60Co unit speciﬁcations
his study was performed on three HDR 60Co sources of a
ZP6 afterloading unit (Nuclear Power Institute of China). This
nit uses six linear braid type sources including one step-
ing and ﬁve non-stepping sources for intracavitary treatment
uch as malignancies of the cervix, rectum, oesophagus and
asopharynx. The sources consist of 60Co active cylinders
length=3.5 cm, diameter = 1.5mm) sealed by titanium cap-
ules and inactive steel balls (diameter = 1.5mm) which are
overed by a steel spring. The position of active elements is
onstant in the source braid and is not changed for different
reatments. The simulated sources are seen in Fig. 1. The GZP6
reatment planning systemuses the Sievert integral to provide
he 3D dose distribution around brachytherapy sources. The
lassical Sievert integral is generalized to 3D radioactivity dis-
ributions, incorporating photon attenuation and scattering
y the surrounding medium. In the previous study a detailed
xplanation of the Sievert integral was provided.10,16
.2. Monte Carlo simulations
he MCNP4C radiation transport code was used for MC
alculations.17 This code allows for the development of
etailed three dimensional models of brachytherapy sources
nd dose calculations in complex geometries and materi-
ls. The detailed simulation of photon transport includes
hotoelectric absorption with the creation of K- and L-shell
uorescent photons and auger electrons, coherent and inco-
erent scattering, and pair production. The simulations were
one in photon mode and energy cut-off of 1 keV was used
or low energy photons. The sources were simulated using
hysical measurements and information provided by the
anufacturer. The active cores were considered as cylinders
omposed of 60Co with uniform distribution of radioactive
aterial. Two photons with emission probabilities of 0.5 and
nergies of 1.17 and 1.33MeV were deﬁned in the source def-
nition card. For dose calculations in water, a phantom with
imensions of 30 cm×30 cm×30 cm was simulated. The sim-
lated sources were located at the centre of the simulatedtherapy 1 4 ( 2 0 1 0 ) 200–204 201
water phantom.The steel vaginal applicatorwith thediameter
of 7mm was also simulated, used with all sources. Absorbed
doses in the water phantom were calculated in a matrix of
scoring cells around the sources using the lattice feature of
MCNP4C code. In otherwords, thewater phantomwas divided
into cells with the dimension of 1mm×1mm×1mm. Using
the tally scoring feature in a lattice, the absorbed doses in the
cells located in a plane vertical to the source longitudinal axis
were tallied. Using MATLAB software (Ver. 7), an m-ﬁle was
written and isodose distributions with distinct intervals were
obtained.
The *F8 tally which scores the absorbed energy in terms
of MeV was used for absorbed dose calculation in each cell.
The energy deposited in each cell was scored per simulation
in terms of MeV. For isodose calculation, the absorbed doses
were normalized to the value of the cell located at the distance
of 1 cm from the source centre. 500 million photons were run
to acquire less than 1% statistical uncertainty in a scoring cell
at a distance of 4 cm from the source centre.
4. Results and discussion
The comparison of isodose distribution is shown in Figs. 2–4.
The absorbed dose in each scoring cell was normalized to
the cell at the distance of 1 cm from the source centre on
the transverse axis for both methods. Comparing isodose dis-
tributions for all three sources showed a close agreement
between the two methods. A quantitative evaluation of iso-
doses revealed that there is a difference of 0.5–1mm between
isodose lines from 500% to 10%. For isodose lines of 500%
in source 1 and 400% in sources 2 and 3 there was a 1mm
geometric difference, which corresponds to a 15% difference
in isodose values. The reason for greater differences in the
isodose lines near the sources was that a steep dose gra-
dient exists in the near ﬁeld region. For other isodose lines
which are farther than about 7mm, the geometric difference
was less than 1mm, which caused less than 2% difference
in isodose values because of a smoother dose gradient. Oth-
erwise, it was found that the discrepancy between MC and
TPS calculation at points close to the source is greater for
source 2 because of longer length. The TPS used point source
geometry for dose calculation in water but in MC calcula-
tions the actual physical sourcewas simulated and this caused
large differences in points close to the source. But for points
located farther than the normalization point (at 1 cm from the
source axis) in all cases, the TPS calculations were accurate
enough to be employed for different brachytherapy treat-
ments. The results of the current study are in accordance
with the research of DeMarco et al. on 125I seeds, in which
a large discrepancy between calculated and measured values
was observed due to the assumption of point source geometry
in calculations.18
In spite of the observed discrepancies, we think that the
TPS calculations are comparable to MC results in all cases.
In source 1, as can be seen, there are some discrepancies up
to 25% beyond the applicator tip at the isodose line of 10% due
the pronounced attenuation of inactive steel balls. This can be
taken into account by theMCmethod. But the TPS cannot con-
sider the attenuation because of its implemented algorithm.
202 reports of practical oncology and radiotherapy 1 4 ( 2 0 1 0 ) 200–204
id type sources used for intracavitary treatments.Fig. 1 – Schematic diagrams of GZP6 60Co bra
At points beyond the tip of the applicator and far from active
sources the attenuation of steel balls is enhanced, resulting
in great differences between MC and TPS calculations. This
problem also exists for the two other sources, but it happens
in much narrower polar angles for points beyond the applica-
Fig. 2 – Comparison of MC and GZP6 calculated isodose
distributions for source 1.Fig. 3 – Comparison of MC and GZP6 calculated isodose
distributions for source 2.
reports of practical oncology and radio
Fig. 4 – Comparison of MC and GZP6 calculated isodose
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GZP6 brachytherapy afterloading unit. Rep Pract Oncolistributions for source 3.
or tips. There is a close agreement with the study of Fragoso
t al. in which the dose distribution delivered by low dose
ate Cs-137 brachytherapy sources was investigated using MC
echniques and polymer gel dosimetry.19 Their results showed
ifferences in dose as large as 20%, beyond the applicator tip,
etween MC and TPS methods. The discrepancy was ascribed
o the presence of stainless steel in the applicator and source
et, which were not considered by the TPS calculations.
The Sievert integral method has shown acceptable accu-
acy in dose calculation for different type brachytherapy
ources. In a study, the Sievert integral method was repeated
or different brachytherapy sources.20 The modiﬁed Sievert
ethod calculated dose distributions for a wide range of
ources with good accuracy, while the classical Sievert model
ailed to accurately calculate dose distributions around highly
ltered sources emitting photons with average energies of
8–400keV.
Our results are in agreement with the results of Wallace
t al. In their study, the transverse radial dose distribution
round the Nucletron MicroSelectron high dose rate (HDR)
92Ir brachytherapy source was studied usingMCNPMC code.3
hey observed signiﬁcant differences between the planning
omputer results and theMonte Carlo dose calculations in the
ear ﬁeld (radius less than 1 cm). The observed discrepancy
as attributed to the HDR brachytherapy planning comput-
rs, which employ algorithms based on a point source with
ttenuation and scatter correction methods.
. Conclusion
n the current investigation we used MCNP4C code to gener-
te two dimensional dose distributions for three braid type
0Co sources and compared them with TPS provided isodose
istributions. Overall, the MC results were in good agreement
ith TPS calculated isodoses. However, there was a small dis-
repancy at points beyond the tip of sources because of thetherapy 1 4 ( 2 0 1 0 ) 200–204 203
algorithm used in the TPS. Finally our results validated the
TPS isodose calculations for clinical use in HDR brachyther-
apy.
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